from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1247c/relB

LFCtreatmentdescriptionclass of inhibitor

-0.646

Amikacinug/mL Amikacintranslation

-0.389

Cap5-10ug/mL Capreomycintranslation

0.224

Rox10-50 ug/mL Roxithromycintranslation

0.763

SM2-5 ug/mL Streptomycintranslation

-0.388

Tet5-10 ug/mL Tetracyclinetranslation

-0.655

Rif0.2-5ug/mL Rifampicintranscription

-0.109

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.081

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.718

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.995

CPZ10-50 ug/mL Chlorpromazinerespiration

1.053

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.223

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.365

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.580

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.399

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.253

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.277

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.438

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.761

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.712

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.013

KCN5-20 ug/mL Potassium cyaniderespiration

0.360

NaN30.2-2 mM Sodium aziderespiration

1.767

Nigericin50 uM Nigericinrespiration

1.180

TRC10-150 ug/mL Triclosanrespiration

1.162

TRZ10-25 ug/mL Thioridazinerespiration

0.838

Valinomycin0.5-10 uM Valinomycinrespiration

-0.690

ZnSO42 mM ZnSO4respiration

0.264

menadione6-10 ug/mL Menadionerespiration

0.345

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.266

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.115

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.367

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.083

NRP_1Non-replicating persistence stage 1dosRassociated

0.353

Amp0.2mg/mL AmpicillincellWall

-0.127

Cephalexin20-100 ug/mL CephalexincellWall

0.659

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.084

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.393

EMB10-20 ug/mL EthambutolcellWall

0.748

Eta12-40 ug/mL EthionamidecellWall

0.768

INH0.2-0.4 ug/mL IsoniazidcellWall

0.033

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.966

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.607

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.025

BZA0.12 mg/mL BenzamidearomaticAmides

-0.570

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.453

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.387

H2O24 mM hydrogen peroxideDNAdamaging

-0.288

Levo10 ug/mL LevofloxacinDNAdamaging

-0.607

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.239

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.015

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.386

UVUV-irradiationDNAdamaging

-0.954

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.505

Antimycin12.5-50 ug/mL Antimycin A?

0.054

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.078

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.123

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.036

PA8240.2-2 ug/mL PA-824?

-1.045

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.983

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.236

Verapamil50 uM Verapamil?

-0.372

mercaptoethanol2 mM 2-Mercaptoethanol?

0.312

methoxatin10-20 ug/mL Methoxatin?